- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about FR:SAN
Recent news which mentions FR:SAN
NatWest shares plunge as bank cuts guidance and admits ‘serious failings’ in treatment of Brexit campaigner Nigel Farage
October 27, 2023
From MarketWatch
Tickers
SNY
From MarketWatch
This fund shows that industry expertise can help you make a lot of money in the stock market
October 02, 2023
From MarketWatch
Coinbase’ stock tumbles on SEC warning, while First Republic and Regeneron shares rally, and other stocks on the move
March 23, 2023
From MarketWatch
From MarketWatch
From MarketWatch
Tickers
SNY
From MarketWatch
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
January 13, 2023
From MarketWatch
From MarketWatch
Amgen reportedly in talks to buy Horizon Therapeutics
December 12, 2022
From MarketWatch
Banks are short more than $1 trillion in capital, this analyst says, who fears the shortfall will only get worse
November 30, 2022
From MarketWatch
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
November 11, 2022
Tickers
GSK
From MarketWatch
Tickers
SNY
From MarketWatch
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
September 14, 2022
From MarketWatch
From MarketWatch
GSK defends Zantac ahead of trials that have cratered the stock
August 12, 2022
From MarketWatch
From MarketWatch
From MarketWatch
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deaths
February 23, 2022
From MarketWatch
From MarketWatch
Omicron variant remains a ‘very high’ risk as it spreads fast and shows resistance to vaccines, but WHO says more data needed to know if it’s more lethal
December 15, 2021
From MarketWatch
From MarketWatch
Hopes rise that Pfizer COVID-19 vaccine will be authorized for use in children aged 5 to 11 by late October, and Russia suffers worst one-day death toll
September 28, 2021
From MarketWatch
U.S. stock futures point to losses for Wall Street as delta worries linger
September 08, 2021
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.